✦ LIBER ✦

P1890 Serum adiponectin in chronic hepatitis C and B

✍ Scribed by Siagris, D.; Lekkou, A.; Vafiadis, G.; Michalaki, M.; Starakis, I.; Makri, M.; Margaritis, V.; Tsamandas, A.; Labropoulou-Karatza, C.

Book ID: 122197407
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 56 KB
Volume: 29
Category: Article
ISSN: 0924-8579
DOI: 10.1016/S0924-8579(07)71729-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum adiponectin in chronic hepatitis C

Serum adiponectin in chronic hepatitis C and B

✍ D. Siagris; G. Vafiadis; M. Michalaki; A. Lekkou; I. Starakis; M. Makri; V. Marg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

Adiponectin in chronic hepatitis C

✍ Arano, Toru; Nakagawa, Hayato; Ikeda, Hitoshi; Koike, Kazuhiko 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 143 KB

P.421 Serum adiponectin levels are assoc

P.421 Serum adiponectin levels are associated with the severity of liver steatosis in chronic hepatitis B or C

✍ E. Tsochatzis; G.V. Papatheodoridis; E. Hadziyannis; A. Georgiou; N. Chrysanthos 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Adiponectin and its receptors in patient

Adiponectin and its receptors in patients with chronic hepatitis C

✍ Julie R. Jonsson; Alexander R. Moschen; Ingrid J. Hickman; Michelle M. Richardso 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 335 KB

P.223 Immunohistochemistry and serum cyt

P.223 Immunohistochemistry and serum cytokines in chronic hepatitis C patients

✍ A.T. R-Viso; C. Pagliari; E.R. Fernandes; C.C. Romano; S. Ogusuku; G. Benard; R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 282 KB

Serum level of adiponectin and the risk

Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients

✍ Toru Arano; Hayato Nakagawa; Ryosuke Tateishi; Hitoshi Ikeda; Koji Uchino; Kenic 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 321 KB 👁 1 views

## Abstract Obesity and metabolic syndrome are recognized risk factors for development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C (CHC). Dysregulation of adipokines, particularly the decreased secretion of adiponectin, appears to play a key role. To investigate the assoc